TuHURA Biosciences - 54 Year Dividend History | HURA
Historical dividend payout and yield for TuHURA Biosciences (HURA) since 1971. The current TTM dividend payout for TuHURA Biosciences (HURA) as of January 17, 2025 is $0.00. The current dividend yield for TuHURA Biosciences as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.203B |
$0.000B |
|
TuHURA Biosciences Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA Biosciences Inc., formerly known as Kintara Therapeutics Inc., is based in SAN DIEGO.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
